# Therapeutic Potential of Sodium-glucose Co-transporter-2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists for Patients with Acute Coronary Syndrome: A Review of Clinical Evidence

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/therapeutic-potential-of-sodium-glucose-co-transporter-2-inhibitors-and-glucagon/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Paschalis Karakasis,Dimitrios Patoulias,George Kassimis,Theocharis Koufakis,Aleksandra Klisić,Michael Doumas,Nikolaos Fragakis,Manfredi Rizzo |
| Citations | 30 |
| DOI | 10.2174/0113816128304097240529053538 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://pmc.ncbi.nlm.nih.gov/articles/PMC11475097/pdf/CPD-30-2109.pdf |
| OpenAlex ID | https://openalex.org/W4399979130 |
| PMID | 38910481 |
| Type | article |
| Year | 2024 |

## Paper authors

- [Dimitrios Patoulias](https://scholariq.org/researchers/dimitrios-patoulias/)
- [Nikolaos Fragakis](https://scholariq.org/researchers/nikolaos-fragakis/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Pharmacology and Obesity Treatment](https://scholariq.org/topics/pharmacology-and-obesity-treatment/)
- [Potassium and Related Disorders](https://scholariq.org/topics/potassium-and-related-disorders/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.